Hiroyoshi Yamada

发表

Synthesis and structure-activity relationships of new carbonyl guanidine derivatives as novel dual 5-HT₂B and 5-HT₇ receptor antagonists. Part 2.

Ayako Moritomo, Minoru Okada, Ayako Moritomo, 2013, Bioorganic & medicinal chemistry.

Synthesis and pharmacological evaluation of optically pure, novel carbonyl guanidine derivatives as dual 5-HT2B and 5-HT7 receptor antagonists.

Ayako Moritomo, Hiroyoshi Yamada, Toshihiro Watanabe, 2014, Bioorganic & medicinal chemistry.

Synthesis and structure activity relationships of carbamimidoylcarbamate derivatives as novel vascular adhesion protein-1 inhibitors.

Hiroyoshi Yamada, K. Kadono, S. Yamaki, 2017, Bioorganic & medicinal chemistry.

Synthesis and structure-activity relationships of benzyloxyphenyl derivatives as a novel class of NCX inhibitors: effects on heart failure.

Hiroyoshi Yamada, S. Sakamoto, A. Kakefuda, 2005, Bioorganic & medicinal chemistry.

Discovery of N-(3-{4-[(3-fluorobenzyl)oxy]phenoxy}propyl)-2-pyridin-4-ylacetamide as a potent and selective reverse NCX inhibitor.

Hiroyoshi Yamada, S. Sakamoto, A. Kakefuda, 2005, Chemical & pharmaceutical bulletin.

Discovery of an N-(2-aminopyridin-4-ylmethyl)nicotinamide derivative: a potent and orally bioavailable NCX inhibitor.

Hiroyoshi Yamada, S. Sakamoto, A. Kakefuda, 2005, Bioorganic & medicinal chemistry.

Synthesis and structure-activity relationships of phenoxypyridine derivatives as novel inhibitors of the sodium-calcium exchanger.

Hiroyoshi Yamada, S. Sakamoto, A. Kakefuda, 2004, Bioorganic & medicinal chemistry.

An easy access to 7-methyl-2-naphthalenecarbonitrile.

Hiroyoshi Yamada, Y. Matsumoto, F. Hirayama, 2005, Chemical & pharmaceutical bulletin.

Development of a potent and orally active activator of adenosine monophosphate-activated protein kinase (AMPK), ASP4132, as a clinical candidate for the treatment of human cancer.

Keita Ohnuki, Hiroyoshi Yamada, Tomohiro Yamada, 2020, Bioorganic & medicinal chemistry.

Corrigendum to “Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels” [Bioorg. Med. Chem. 22 (2014) 6899–6907]

M. Inoue, Hiroyoshi Yamada, Toshihiro Watanabe, 2015 .

Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.

M. Inoue, Hiroyoshi Yamada, Toshihiro Watanabe, 2014, Bioorganic & medicinal chemistry.